NS1

NS1 詳細

英語名Src homology phosphotyrosyl phosphatase 2市販薬剤の数0
治験薬の数20ターゲットの別称Protein Tyrosine Phosphatase Non-Receptor Type 11,SHP-2,PTP2C,Protein-tyrosine phosphatase 2C,PTP-2C,PTP-1D,SH-PTP3,PTPN11,Protein-Tyrosine Phosphatase 1D,SH-PTP2,EC:3.1.3.48,Noonan Syndrome 1,EC 3.1.3.48,METCDS,SHPTP2,BPTP3,JMML,SHP2,CFC,NS1,Protein Tyrosine Phosphatase, Non-Receptor Type 11,Tyrosine-Protein Phosphatase Non-Receptor Type 11
研究&開発段階Phase 3 Clinical
英語名Src homology phosphotyrosyl phosphatase 2
ターゲットの別称Protein Tyrosine Phosphatase Non-Receptor Type 11,SHP-2,PTP2C,Protein-tyrosine phosphatase 2C,PTP-2C,PTP-1D,SH-PTP3,PTPN11,Protein-Tyrosine Phosphatase 1D,SH-PTP2,EC:3.1.3.48,Noonan Syndrome 1,EC 3.1.3.48,METCDS,SHPTP2,BPTP3,JMML,SHP2,CFC,NS1,Protein Tyrosine Phosphatase, Non-Receptor Type 11,Tyrosine-Protein Phosphatase Non-Receptor Type 11
市販薬剤の数0
治験薬の数20
研究&開発段階Phase 3 Clinical

お問い合わせ

NS1バックグランド

Zika virus (ZIKV) is a member of the virus family Flaviviridae and the genus Flavivirus, transmitted by daytime-active Aedes mosquitoes, such as A. aegypti and A. albopictus. Its name comes from the Zika Forest of Uganda, where the virus was first isolated in 1947. Zika virus is related to dengue, yellow fever, Japanese encephalitis, and West Nile viruses. The infection, known as Zika fever, often causes no or only mild symptoms, similar to a mild form of dengue fever. It is treated by rest. Since the 1950s, it has been known to occur within a narrow equatorial belt from Africa to Asia. As of 2016, the illness cannot be prevented by drugs or vaccines. As of February 2016, there is evidence that Zika fever in pregnant women is associated with abnormal brain development in their fetuses through mother-to-child transmission of the virus, which may result in miscarriage or microcephaly.

NS1分子の別称

NS1

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
JAB-3312JAB-3312Phase 3 ClinicalJacobio Pharmaceuticals Co LtdSolid tumours; Squamous Cell Carcinoma of Head and Neck; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung
詳細
JAB-3068JAB-3068Phase 2 ClinicalJacobio Pharmaceuticals Co Ltd, Abbvie IncSolid tumours; Head and Neck Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Adenoid Cystic; Esophageal Squamous Cell Carcinoma; Lymphoma; Carcinoma, Non-Small-Cell Lung
詳細
VociprotafibRMC-4630; SAR-442720Phase 2 ClinicalSanofi, Revolution Medicines IncSolid tumours; Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis
詳細
BatoprotafibTNO-155Phase 2 ClinicalNovartis Pharma AgSolid tumours; Squamous Cell Carcinoma of Head and Neck; Renal Insufficiency; Neoplasms; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Hepatic Insufficiency; Lung Neoplasms; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma
詳細
GH-21GH 21005; GH-21; HBI-2376Phase 2 ClinicalSuzhou GenHouse pharmaceutical Co LtdSolid tumours; Head and Neck Neoplasms; Colonic Neoplasms; Pancreatic Neoplasms; Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung
詳細
BR-790BR-790Phase 2 ClinicalJiangxi Qingfeng Pharmaceutical Industry Co LtdSolid tumours; Neoplasms; Carcinoma, Non-Small-Cell Lung
詳細
BBP-398IACS-15509; BBP-398; IACS-13909; BMS-986466Phase 2 ClinicalBridgebio Pharma Inc, The University Of Texas MD Anderson Cancer CenterSolid tumours; Carcinoma, Non-Small-Cell Lung
詳細
MigoprotafibRLY-1971; GDC-1971; RO-7517834; RG-6433Phase 1 ClinicalRelay Therapeutics IncSolid tumours; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung
詳細
A-380A-380Phase 1 ClinicalShandong Kelun Phaemaceutical Co Ltd, Klus Pharma IncNeoplasms
詳細
KYHY-2303KYHY2303; KYHY-2303Phase 1 ClinicalJiangsu Kanion Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of SciencesHematologic Neoplasms
詳細
RG-001RG001; RG-001Phase 1 ClinicalShanghai Lingji Biological Technology Co LtdNeoplasms
詳細
HS-336HS336; HS-336Phase 1 ClinicalZhejiang Hisun Pharmaceutical Co LtdSolid tumours
詳細
HMPL-415S1HMPL-415S1Phase 1 ClinicalHutchison Medipharma LtdSolid tumours
詳細
BPI-442096Phase 1 ClinicalBetta Pharmaceuticals Co LtdSolid tumours; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung
詳細
HS-10381HS-10381Phase 1 ClinicalJiangsu Hansoh Pharmaceutical Group Co LtdSolid tumours
詳細
ET-0038ET-0038Phase 1 ClinicalShanghai Yituo Pharmaceutical Technology Co LtdSolid tumours
詳細
PF-07284892ARRY-558; PF-07284892Phase 1 ClinicalPfizer IncSolid tumours; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung
詳細
ICP-189ICP-189Phase 1 ClinicalInnoCare Pharma LtdSolid tumours; Carcinoma, Non-Small-Cell Lung
詳細
ERAS-601ERAS-601Phase 1 ClinicalErasca IncSolid tumours; Leukemia, Myeloid, Acute
詳細
SH-3809SH3809Phase 1 ClinicalNanjing Sanhome Pharmaceutical Co Ltd Solid tumours
詳細
  • 詳細
  • お問い合わせ
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8